Holger Bronger - Concepedia

Author

Holger Bronger

Technical University of Munich ORCID

Also Known As

Antje Belau, Bronger, Holger, F. Heitz, H Bronger, H. Bronger, HOLGER BRONGER, Holger Bronger, Thomas Beck

166

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Technical University of Munich Klinikum rechts der Isar German Cancer Research Center Heidelberg University Helmholtz Zentrum München

About

Holger Bronger is an author at Technical University of Munich specializing in tumor biology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	442
2	Cell Biology	4	4	375
3	Engineering	1	1	26
4	Biochemistry	1	1	295
5	Immunology	1	1	15

Holger Bronger

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
ABCC Drug Efflux Pumps and Organic Anion Uptake Transporters in Human Gliomas and the Blood-Tumor Barrier Holger Bronger, Jörg König, Kathrin Kopplow, Cancer Research High-grade GliomasGliomaTumor BiologyNeuro-oncologyBlood-tumor Barrier	2005	295
CXCL9 and CXCL10 predict survival and are regulated by cyclooxygenase inhibition in advanced serous ovarian cancer Holger Bronger, J. David Singer, Claudia Windmüller, British Journal of Cancer	2016	257
Molecular Analysis of HER2 Signaling in Human Breast Cancer by Functional Protein Pathway Activation Mapping Julia Wulfkuhle, Daniela Berg, Claudia Wolff, Clinical Cancer Research	2012	120
Prognosis of ovarian cancer is associated with effector memory CD8<sup>+</sup> T cell accumulation in ascites, CXCL9 levels and activation-triggered signal transduction in T cells Sonja Lieber, Silke Reinartz, Hartmann Raifer, OncoImmunology	2018	89
Modulation of CXCR3 ligand secretion by prostaglandin E2 and cyclooxygenase inhibitors in human breast cancer Holger Bronger, Sara Kraeft, Ulrike Schwarz‐Boeger, Breast Cancer Research	2012	72
Sarcopenia in Advanced Serous Ovarian Cancer Holger Bronger, Philipp Hederich, Alexander Hapfelmeier, International Journal of Gynecological Cancer	2016	67
CXCL9 inhibits tumour growth and drives anti-PD-L1 therapy in ovarian cancer Stefanie Seitz, Tobias Dreyer, Christoph Stange, British Journal of Cancer	2022	65
MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer Mithu Raychaudhuri, Holger Bronger, Theresa Buchner, Breast Cancer Research and Treatment Breast OncologyOncologyMedicinePathologyCancer Genomics	2017	52
Signalling networks associated with urokinase‐type plasminogen activator (uPA) and its inhibitor PAI‐1 in breast cancer tissues: new insights from protein microarray analysis Claudia Wolff, Katharina Malinowsky, Daniela Berg, The Journal of Pathology	2010	41
Induction of cathepsin B by the CXCR3 chemokines CXCL9 and CXCL10 in human breast cancer cells Holger Bronger, Anne Karge, Tobias Dreyer, Oncology Letters	2017	41

Page 1